Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Captopril
(D-2-methyl-3-mercaptopropanoyl-L-proline)		1件: Captopril1件: Captopril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬8件: 6, 17, 46, 86, 96, 97, 107, 271 💬
2 D-Proline
(D-Proline)		1件: D-Proline---1件: 97 💬
3 Enalapril
(L-proline)		2件: Enalapril; Enalapril Maleate1件: Enalapril 💬 1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬6件: 19, 46, 66, 113, 210, 222 💬
4 Histrelin
(L-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-Nim-benzyl-histidyl-L-leucyl-L-arginyl-L-proline ethylamide)		1件: Histrelin1件: Histrelin 💬 1件: GNRHR 💬 2件: GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 76 💬
5 IPL-344
(L-leucyl-l-prolyl-l-prolyl-l-leucyl-l-prolyl-l-tyrosyl-l-proline)		0件: ---1件: 2 💬
6 Lisinopril
(L-proline)		2件: Lisinopril; Zestril2件: Lisinopril ,
Lisinopril 💬 		1件: ACE 💬 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬7件: 19, 46, 49, 66, 67, 113, 222 💬
7 Lixisenatide
(des-38-proline-exendine-4 -peptidylpenta-L-lysyl-L-lysinamide)		1件: Lixisenatide1件: Lixisenatide 💬 1件: GLP1R 💬 3件: Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 6 💬
8 Pidolic acid
(5-oxo-L-proline)		0件: ---1件: 70 💬
9 Proline
(Proline)		1件: Proline1件: Proline (Proline, L-Proline) 💬 --2件: 94, 97 💬
10 Protirelin
(L-pyroglutamyl-L-histidyl-L-prolineamide)		1件: Thyrotropin releasing hormone1件: Protirelin 💬 1件: TRHR 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 80 💬